Abstract:Solid dispersion (SD) technology is one of the most widely preferred solubility enhancement methods, especially for Biopharmaceutics classification system class II and IV drugs. Since the last decade, its application for the dual purpose of solubility hike and modified release using novel carriers has been in demand for its added advantages. Spray drying is a commercially accepted technique with high aspects of scalability and product characteristics. The current study used spray-dried dispersion to design delayed release capsule for the proton pump inhibitor esomeprazole. The SD carrier hydroxypropyl methylcellulose acetate succinate-medium grade (HPMCAS-MF) enhanced solubility, inhibited precipitation of saturated drug solutions, and allowed enteric release owing to its solubility above pH 6. The proposed approach avoided compression, coating with enteric polymers, and the development of multi-particulate pellet-based formulations, improving manufacturing feasibility. The formulation was optimized using Box-Behnken design, considering significant formulation variables like HPMCAS-MF proportion and critical process parameters like feed flow rate and inlet temperature. The optimized spray-dried dispersion were characterized based on Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM) and also evaluated for solubility, in vitro drug release, residual solvent content, and stability testing. Response surface methodology optimization anticipated that formulation variables affected solubility and release profile, whereas CPPs affected yield. The design space was developed via overlay plot based on constraints specified to attain the desired response and validated using three checkpoint batches with desirability 1. FTIR showed active pharmaceutical ingredient-polymer compatibility. Particle size and SEM studies showed spherical particles with an average Z-value of 1.8 µ. DSC and PXRD confirmed SD's amorphous nature. The drug release investigation and release kinetics prediction utilizing DD-solver software showed a 2-h lag time with > 90% cumulative drug release up to 4 h for the DR formulation. ESM SDD were prepared by spray drying technique using the novel solid dispersion carrier HPMCAS-MF to serve the dual purpose of solubility enhancement and delayed release. The ratio of API:carrier and process variables like feed flow rate and inlet temperature were varied using the Box-Behnken Design to determine the design space of optimized product to procure the desired characteristics of solubility improvement compared to crystalline API and delayed release of PPI to avoid the degradation in the gastric environment. The developed formulation represents several benefits over the already existing marketed products.

Design and Evaluation of Bilayer Pump Tablet of Flurbiprofen Solid Dispersion for Zero-Order Controlled Delivery

Preparation, Characterization and Properties of Liposome-Loaded Polycaprolactone Microspheres As a Drug Delivery System

Fabrication of osmotic pump tablets utilizing semisolid extrusion three-dimensional printing technology

Development of a Robust Control Strategy for Fixed-Dose Combination Bilayer Tablets with Integrated Quality by Design, Statistical, and Process Analytical Technology Approach

Exploration and Preparation of Ofloxacin Biphasic Tablets Via Semi-solid Extrusion Technology

Development, QbD-based optimisation, in-vivo pharmacokinetics, and ex-vivo evaluation of Eudragit® RS 100 loaded flurbiprofen nanoparticles for oral drug delivery

Sandwiched Osmotic Pump Tablet for Controlled Release of Water-Insoluble Drug

Design and Evaluation of Osmotic Pump-Based Controlled Release System of Ambroxol Hydrochloride.

Design and evaluation of a dry coated drug delivery system with floating-pulsatile release

Enhanced Dissolution of Silymarin/polyvinylpyrrolidone Solid Dispersion Pellets Prepared by a One-Step Fluid-Bed Coating Technique

Optimization and Characterization of Novel Sustained Release Supermicro-Pellet Based Dry Suspensions That Load Dexibuprofen

Investigation of Critical Core Formulation and Process Parameters for Osmotic Pump Oral Drug Delivery

Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe

Preparation and Quality Evaluation of Ibuprofen Sustained Release Pellet Capsules Based on Solid Dispersion Technology

Investigation Of Nanostructured Lipid Carriers For Transdermal Delivery Of Flurbiprofen

Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol

In Vitro and Biological Evaluation of Oral Fast-Disintegrating Films Containing Ranitidine HCl and Syloid® 244FP-Based Ternary Solid Dispersion of Flurbiprofen

In Vitro and in Vivo Evaluation of Novel Osmotic Pump Tablets of Isosorbide-5-mononitrate Containing Polyvinyl Pyrrolidone (PVP) for Controlled Release.

Preparation of Self-Emulsifying Drug Delivery Systems of Flurbiprofen and Investigation of Dissolution

Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy

Optimization of the Formulation of Bezafibrate Osmotic Pump Tablets by Central Composite Design-response Surface Methodology